{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:54:52Z","timestamp":1767135292499,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd001834.pub2","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2011,7,6]],"date-time":"2011-07-06T00:00:00Z","timestamp":1309910400000},"record-id":"33410"},{"DOI":"10.1002\/14651858.cd001834","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2011,7,6]],"date-time":"2011-07-06T00:00:00Z","timestamp":1309910400000},"record-id":"33411"},{"DOI":"10.1002\/14651858.cd001834.pub2","type":"withdrawal","label":"Withdrawal","source":"publisher","updated":{"date-parts":[[2011,7,6]],"date-time":"2011-07-06T00:00:00Z","timestamp":1309910400000}}],"reference-count":75,"publisher":"Wiley","issue":"7","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd001834.pub3","type":"journal-article","created":{"date-parts":[[2011,7,4]],"date-time":"2011-07-04T16:18:42Z","timestamp":1309796322000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Conjugate vaccines for preventing meningococcal C meningitis and septicaemia"],"prefix":"10.1002","volume":"2011","author":[{"given":"Lucieni O","family":"Conterno","sequence":"first","affiliation":[{"name":"Marilia Medical School; Department of General Internal Medicine and Clinical Epidemiology Unit; Avenida Monte Carmelo 800 Fragata Marilia S\u00e3o Paulo Brazil 17519-030"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos Rodrigues","family":"da Silva Filho","sequence":"additional","affiliation":[{"name":"Marilia Medical School; Department of General Internal Medicine and Clinical Epidemiology Unit; Avenida Monte Carmelo 800 Fragata Marilia S\u00e3o Paulo Brazil 17519-030"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens U","family":"Ruggeberg","sequence":"additional","affiliation":[{"name":"P\u00e4diatrische Infektiologie, Klinik f\u00fcr allgemeine P\u00e4diatrie; Wissenschaftlicher Mitarbeiter Universit\u00e4tskinderklinik; Moorenstr. 5 D\u00fcsseldorf Germany 40225"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul T","family":"Heath","sequence":"additional","affiliation":[{"name":"St. George's, University of London; Division of Child Health and Vaccine Institute; Cranmer Terrace Tooting London UK SW17 0RE"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,7,6]]},"reference":[{"issue":"8","key":"10.1002\/14651858.CD001834.pub3-BIB1|cit1","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1128\/IAI.62.8.3391-3395.1994","article-title":"Safety and immunogenicity of meningococcal A and C polysaccharide conjugate vaccine in adults","volume":"62","author":"Anderson","year":"1994","journal-title":"Infection and Immunity"},{"issue":"10","key":"10.1002\/14651858.CD001834.pub3-BIB2|cit2","doi-asserted-by":"crossref","first-page":"5549","DOI":"10.1128\/IAI.71.10.5549-5555.2003","article-title":"Immunogenicity of, and immunologic memory to, a reduced primary schedule of meningococcal C-tetanus toxoid conjugate vaccine in infants in the United Kingdom","volume":"71","author":"Borrow","year":"2003","journal-title":"Infection and Immunity"},{"issue":"9","key":"10.1002\/14651858.CD001834.pub3-BIB3|cit3","doi-asserted-by":"crossref","first-page":"4946","DOI":"10.1128\/IAI.70.9.4946-4954.2002","article-title":"Effect of vaccination with carrier protein on response to meningococcal C conjugate vaccine and values of different immunoassays as predictors of protection","volume":"70","author":"Burrage","year":"2002","journal-title":"Infection and Immunity"},{"issue":"14","key":"10.1002\/14651858.CD001834.pub3-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1001\/jama.293.14.1751","article-title":"Immunogenicity and safety of a combination pneumococcal-meningococcal vaccine in infants : a randomized clinical trial","volume":"293","author":"Buttery","year":"2005","journal-title":"Journal of American Medical Association"},{"issue":"2","key":"10.1002\/14651858.CD001834.pub3-BIB5|cit5","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/00006454-200002000-00013","article-title":"Safety and immunogenicity of three doses of a Neisseria meningitidis A + C diphtheria conjugate vaccine in infants from Niger","volume":"19","author":"Campagne","year":"2000","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"24","key":"10.1002\/14651858.CD001834.pub3-BIB6|cit6","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1016\/S0264-410X(00)00050-5","article-title":"Immunogenicity and reactogenicity of a group C meningococcal conjugate vaccine compared with a group A+C meningococcal polysaccharide vaccine in adolescents in a randomised observer-blind controlled trial","volume":"18","author":"Choo","year":"2000","journal-title":"Vaccine"},{"issue":"5","key":"10.1002\/14651858.CD001834.pub3-BIB7|cit7","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1128\/IAI.68.5.2692-2697.2000","article-title":"Mucosal immune responses to meningococcal group C conjugate and group A and C polysaccharide vaccines in adolescents","volume":"68","author":"Zhang","year":"2000","journal-title":"Infection and Immunity"},{"key":"10.1002\/14651858.CD001834.pub3-BIB8|cit8","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1001\/jama.292.20.2491","article-title":"Effectiveness of a mass immunization campaign using serogroup C meningococcal conjugate vaccine","volume":"292","author":"Wals","year":"2004","journal-title":"The Journal of American Medical Association"},{"issue":"9-10","key":"10.1002\/14651858.CD001834.pub3-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/S0264-410X(00)00241-3","article-title":"A randomised, double-blind, controlled trial of the immunogenicity and tolerability of a meningococcal group C conjugate vaccine in young British infants","volume":"19","author":"English","year":"2000","journal-title":"Vaccine"},{"issue":"3","key":"10.1002\/14651858.CD001834.pub3-BIB10|cit10","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1086\/338474","article-title":"Natural and vaccine-induced immunity and immunologic memory to Neisseria meningitidis serogroup C in young adults","volume":"185","author":"Goldblatt","year":"2002","journal-title":"Journal of Infectious Diseases"},{"issue":"6","key":"10.1002\/14651858.CD001834.pub3-BIB11|cit11","first-page":"243","article-title":"Simultaneous administration of meningococcal C conjugate vaccine and diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine in children: a randomized double-blind study","volume":"25","author":"Halperin","year":"2002","journal-title":"Clinical & Investigative Medicine - Medecine Clinique et Experimentale"},{"issue":"31-2","key":"10.1002\/14651858.CD001834.pub3-BIB12|cit12","doi-asserted-by":"crossref","first-page":"3778","DOI":"10.1016\/S0264-410X(02)00318-3","article-title":"Prior meningococcal A\/C polysaccharide vaccine does not reduce immune responses to conjugate vaccine in young adults","volume":"20","author":"Lakshman","year":"2002","journal-title":"Vaccine"},{"issue":"7","key":"10.1002\/14651858.CD001834.pub3-BIB13|cit13","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1128\/IAI.69.7.4337-4341.2001","article-title":"Primary and booster mucosal immune responses to meningococcal group A and C conjugate and polysaccharide vaccines administered to university students in the United Kingdom","volume":"69","author":"Zhang","year":"2001","journal-title":"Infection and Immunity"},{"key":"10.1002\/14651858.CD001834.pub3-BIB14|cit14","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1016\/j.vaccine.2005.03.045","article-title":"Impact and effectiveness of meningococcal C conjugate vaccine following its introduction in Spain","volume":"23","author":"Larrauri","year":"2005","journal-title":"Vaccine"},{"issue":"19","key":"10.1002\/14651858.CD001834.pub3-BIB15|cit15","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1001\/jama.1996.03530430043037","article-title":"Safety and immunogenicity of a serogroups A\/C Neisseria meningitidis oligosaccharide-protein conjugate vaccine in young children. A randomized controlled trial","volume":"275","author":"Lieberman","year":"1996","journal-title":"Journal of the American Medical Association"},{"issue":"19","key":"10.1002\/14651858.CD001834.pub3-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1001\/jama.280.19.1685","article-title":"Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers: a randomized controlled trial","volume":"280","author":"MacDonald","year":"1998","journal-title":"Journal of the American Medical Association"},{"issue":"1","key":"10.1002\/14651858.CD001834.pub3-BIB17|cit17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.7748\/paed2001.02.13.1.23.c720","article-title":"Group C meningococcal vaccine trial: safety, immunogenicity and parents' views of participation","volume":"13","author":"Jonas","year":"2001","journal-title":"Paediatric Nursing"},{"issue":"21","key":"10.1002\/14651858.CD001834.pub3-BIB18|cit18","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1001\/jama.283.21.2795","article-title":"Safety, immunogenicity, and induction of immunologic memory by a serogroup C meningococcal conjugate vaccine in infants: A randomized controlled trial","volume":"283","author":"MacLennan","year":"2000","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD001834.pub3-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/S0140-6736(02)08679-8","article-title":"Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination","volume":"359","author":"Maiden","year":"2002","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD001834.pub3-BIB20|cit20","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/01.inf.0000148928.10057.86","article-title":"Comparative trial of the safety and immunogenicity of quadrivalent (A, C, Y, W-135) meningococcal polysaccharide-diphtheria conjugate vaccine versus quadrivalent polysaccharide vaccine in two- to ten-year-old children","volume":"24","author":"Pichichero","year":"2005","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"2","key":"10.1002\/14651858.CD001834.pub3-BIB21|cit21","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1086\/315284","article-title":"Meningococcal C polysaccharide vaccine induces immunologic hyporesponsiveness in adults that is overcome by meningococcal C conjugate vaccine","volume":"181","author":"Richmond","year":"2000","journal-title":"Journal of Infectious Diseases"},{"issue":"1","key":"10.1002\/14651858.CD001834.pub3-BIB22|cit22","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1086\/317646","article-title":"Ability of 3 different meningococcal C conjugate vaccines to induce immunologic memory after a single dose in UK toddlers","volume":"183","author":"Richmond","year":"2001","journal-title":"Journal of Infectious Diseases"},{"issue":"12","key":"10.1002\/14651858.CD001834.pub3-BIB23|cit23","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/01.inf.0000145427.19167.35","article-title":"Immunogenicity and reactogenicity of a three-dose primary vaccination course with a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-haemophilus influenzae type b vaccine coadministered with a meningococcal C conjugate vaccine","volume":"23","author":"Tejedor","year":"2004","journal-title":"The Pediatric Infectious Disease Journal"},{"key":"10.1002\/14651858.CD001834.pub3-BIB24|cit24","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0140-6736(04)16725-1","article-title":"Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction","volume":"364","author":"Trotter","year":"2004","journal-title":"The Lancet"},{"key":"10.1002\/14651858.CD001834.pub3-BIB25|cit25","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/infdis\/175.1.200","article-title":"Induction of immunologic memory in gambia children by vaccination in infancy with a group A plus C meningococcal polysaccharide-protein conjugate vaccine","volume":"175","author":"Leach","year":"1997","journal-title":"The Journal of Infectious Diseases"},{"issue":"1","key":"10.1002\/14651858.CD001834.pub3-BIB26|cit26","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1086\/317667","article-title":"Immunologic memory 5 years after meningococcal A\/C conjugate vaccination in infancy","volume":"183","author":"MacLennan","year":"2001","journal-title":"Journal of Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD001834.pub3-BIB27|cit27","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1093\/infdis\/171.3.632","article-title":"A trial of a group A plus group C Meningococcal polysaccharide-protein conjugate vaccine in African infants","volume":"171","author":"Twumasi Jr","year":"1995","journal-title":"Journal of Infectious Diseases"},{"issue":"1","key":"10.1002\/14651858.CD001834.pub3-BIB28|cit28","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1128\/IAI.72.1.332-337.2004","article-title":"Immune response to meningococcal serogroup C conjugate vaccine in asplenic individuals","volume":"72","author":"Balmer","year":"2004","journal-title":"Infection and Immunity"},{"issue":"3","key":"10.1002\/14651858.CD001834.pub3-BIB29|cit29","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1017\/S0950268899003787","article-title":"Induction of immunological memory in UK infants by a meningococcal A\/C conjugate vaccine","volume":"124","author":"Borrow","year":"2000","journal-title":"Epidemiology and Infection"},{"issue":"3","key":"10.1002\/14651858.CD001834.pub3-BIB30|cit30","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1086\/322024","article-title":"Influence of prior meningococcal C polysaccharide vaccination on the response and generation of memory after meningococcal C conjugate vaccination in young children","volume":"184","author":"Borrow","year":"2001","journal-title":"Journal of Infectious Diseases"},{"issue":"9358","key":"10.1002\/14651858.CD001834.pub3-BIB31|cit31","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0140-6736(03)12563-9","article-title":"Effectiveness of meningococcal C conjugate vaccine in teenagers in England","volume":"361","author":"Bose","year":"2003","journal-title":"Lancet"},{"issue":"20-22","key":"10.1002\/14651858.CD001834.pub3-BIB32|cit32","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1016\/S0264-410X(00)00528-4","article-title":"Safety and immunogenicity of three lots of meningococcal serogroup C conjugate vaccine administered at 2, 3 and 4 months of age","volume":"19","author":"Bramley","year":"2001","journal-title":"Vaccine"},{"key":"10.1002\/14651858.CD001834.pub3-BIB33|cit33","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1086\/345763","article-title":"Safety, Reactogenicity and Immunogenicity of a tetravalent meningococcal polysaccharide-diphtheria toxoid conjugate vaccine given to health adults","volume":"186","author":"Campbell","year":"2002","journal-title":"The Journal of Infectious Diseases"},{"issue":"10","key":"10.1002\/14651858.CD001834.pub3-BIB34|cit34","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/0264-410X(92)90091-W","article-title":"Development and phase 1 clinical testing of a conjugate vaccine against meningococcus A and C","volume":"10","author":"Costantino","year":"1992","journal-title":"Vaccine"},{"key":"10.1002\/14651858.CD001834.pub3-BIB35|cit35","doi-asserted-by":"crossref","unstructured":"Granoff DM Shannon L Harris L Protective activity of group C anticapsular antibodies elicited in two-year-olds by an investigational quadrivalent Neisseria meningitidis-Diphtheria toxoid conjugate -vaccine The Pediatrics Infectious Disease Journal 2004 490 7","DOI":"10.1097\/01.inf.0000129686.12470.e6"},{"key":"10.1002\/14651858.CD001834.pub3-BIB36|cit36","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1136\/adc.85.5.391","article-title":"Safety of a new conjugate meningococcal C vaccine in infants","volume":"85","author":"Lakshman","year":"2001","journal-title":"Archives of Diseases of Children"},{"key":"10.1002\/14651858.CD001834.pub3-BIB37|cit37","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00006454-200203000-00010","article-title":"Mucosal immune responses to meningococcal conjugate vaccines in infants","volume":"21","author":"Zhang","year":"2002","journal-title":"Pediatric Infectious Diseases"},{"issue":"23-4","key":"10.1002\/14651858.CD001834.pub3-BIB38|cit38","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1016\/S0264-410X(99)00139-5","article-title":"Immune response to revaccination with meningococcal A and C polysaccharides in Gambian children following repeated immunisation during early childhood","volume":"17","author":"MacLennan","year":"1999","journal-title":"Vaccine"},{"key":"10.1002\/14651858.CD001834.pub3-BIB39|cit39","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/00006454-200208000-00010","article-title":"Safety and immunogenicity of meningococcus serogroup C conjugate vaccine administered as a primary or booster vaccination to health four-year-old children","volume":"21","author":"Mcvernon","year":"2002","journal-title":"Pediatrics Infectious Diseases"},{"issue":"19-20","key":"10.1002\/14651858.CD001834.pub3-BIB40|cit40","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1016\/S0264-410X(03)00058-6","article-title":"Effect of infant immunisation with meningococcus serogroup C-CRM(197) conjugate vaccine on diphtheria immunity and reactogenicity in pre-school aged children","volume":"21","author":"McVernon","year":"2003","journal-title":"Vaccine"},{"issue":"2","key":"10.1002\/14651858.CD001834.pub3-BIB41|cit41","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00006454-200102000-00007","article-title":"Safety and immunogenicity of four doses of Neisseria meningitidis group C vaccine conjugated to CRM197 in United States infants","volume":"20","author":"Rennels","year":"2001","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"10","key":"10.1002\/14651858.CD001834.pub3-BIB42|cit42","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1097\/00006454-200210000-00019","article-title":"Dose escalation, safety and immunogenicity study of a tetravalent meninogococcal polysaccharide diphtheria conjugate vaccine in toddlers","volume":"21","author":"Rennels","year":"2002","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"5","key":"10.1002\/14651858.CD001834.pub3-BIB43|cit43","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/01.inf.0000126297.28952.f8","article-title":"Dosage escalation, safety and immunogenicity study of four dosages of a tetravalent meninogococcal polysaccharide diphtheria toxoid conjugate vaccine in infants","volume":"23","author":"Rennels","year":"2004","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"5","key":"10.1002\/14651858.CD001834.pub3-BIB44|cit44","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1128\/CDLI.7.5.764-768.2000","article-title":"Relationship between serum bactericidal activity and serogroup-specific immunoglobulin G concentration for adults, toddlers, and infants immunized with neisseria meningitidis serogroup C vaccines.","volume":"7","author":"Sikkema","year":"2000","journal-title":"Clinical & Diagnostic Laboratory Immunology"},{"issue":"2","key":"10.1002\/14651858.CD001834.pub3-BIB45|cit45","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/01.inf.0000151029.58752.27","article-title":"Lack of serum bactericidal activity in preschool children two years after single dose of serogroup C meningococcal polysaccharide-protein conjugate vaccine","volume":"24","author":"Snape","year":"2005","journal-title":"The Pediatric Infectious Disease Journal"},{"issue":"3","key":"10.1002\/14651858.CD001834.pub3-BIB46|cit46","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/00006454-200203000-00010","article-title":"Mucosal immune response to meningococcal conjugate polysaccharide vaccines in infants","volume":"21","author":"Zhang","year":"2002","journal-title":"Pediatrics Infectious Diseases"},{"key":"10.1002\/14651858.CD001834.pub3-BIB47|cit47","article-title":"Analysing and presenting results","volume-title":"Cochrane Reviewers\u2019 Handbook 4.2.2 [updated December 2003]. Section 8","author":"Alderson","year":"2003"},{"issue":"5","key":"10.1002\/14651858.CD001834.pub3-BIB48|cit48","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1128\/CDLI.10.5.780-786.2003","article-title":"Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in England","volume":"10","author":"Andrews","year":"2003","journal-title":"Clinical Diagnostic and Laboratory Immunology"},{"issue":"10","key":"10.1002\/14651858.CD001834.pub3-BIB49|cit49","first-page":"205","article-title":"Annual report of the Australian Meningococcal Surveillance Programme, 1997","volume":"22","author":"Anonymous","year":"1998","journal-title":"Communicable Diseases Intelligence"},{"issue":"3","key":"10.1002\/14651858.CD001834.pub3-BIB50|cit50","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1128\/IAI.69.3.1568-1573.2001","article-title":"Serological basis for use of meningococcal serogroup C conjugate vaccine in the United Kingdom: reevaluation of correlates of protection","volume":"69","author":"Borrow","year":"2001","journal-title":"Infection and Immunity"},{"issue":"Suppl","key":"10.1002\/14651858.CD001834.pub3-BIB51|cit51","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1128\/CMR.2.Suppl.S118","article-title":"Global Epidemiology of Meningococcal Disease","volume":"2","author":"Schwartz","year":"1989","journal-title":"Clinical Microbiology Reviews"},{"issue":"31","key":"10.1002\/14651858.CD001834.pub3-BIB52|cit52","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.1016\/S0264-410X(01)00205-5","article-title":"Meningococcal disease in Europe: epidemiology, mortality, and prevention with conjugate vaccines. Report of a European advisory board meeting Vienna, Austria, 6-8 October, 2000","volume":"19","author":"Cartwright","year":"2001","journal-title":"Vaccine"},{"key":"10.1002\/14651858.CD001834.pub3-BIB53|cit53","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1017\/S0950268898001848","article-title":"Is group C meningococcal disease increasing in Europe? A report of surveillance of meningococcal infection in Europe 1993-6","volume":"122","author":"Connolly","year":"1999","journal-title":"Epidemiology and Infection"},{"issue":"16","key":"10.1002\/14651858.CD001834.pub3-BIB54|cit54","first-page":"121","article-title":"Surveillance of invasive meningococcal disease in Canada, 1995-1996","volume":"23","author":"Deeks","year":"1997","journal-title":"Canada Communicable Disease Report"},{"issue":"5","key":"10.1002\/14651858.CD001834.pub3-BIB55|cit55","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1086\/520303","article-title":"Complications and sequelae of meningococcal disease in Quebec, Canada, 1990-1994","volume":"26","author":"Erickson","year":"1998","journal-title":"Clinical Infectious Diseases"},{"key":"10.1002\/14651858.CD001834.pub3-BIB56|cit56","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/ije\/22.4.742","article-title":"Estimation of vaccine effectiveness using the screening method","volume":"22","author":"Farrington","year":"1993","journal-title":"International Journal of Epidemiologia"},{"issue":"5","key":"10.1002\/14651858.CD001834.pub3-BIB57|cit57","doi-asserted-by":"crossref","first-page":"690-7 \u00a0","DOI":"10.1093\/infdis\/140.5.690","article-title":"Kinetics of antibody production to group A and group C meningococcal polysaccharide vaccines administered during the first six years of life: prospects for routine immunization of infants and children","volume":"140","author":"Gold","year":"1979","journal-title":"Journal of Infectious Diseases"},{"issue":"6","key":"10.1002\/14651858.CD001834.pub3-BIB58|cit58","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1084\/jem.129.6.1307","article-title":"Human immunity to the meningococcus. I. The role of humoral antibodies","volume":"129","author":"Goldschneider","year":"1969","journal-title":"Journal of Experimental Medicine"},{"issue":"3","key":"10.1002\/14651858.CD001834.pub3-BIB59|cit59","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1086\/515346","article-title":"Induction of immunologic refractoriness in adults by meningococcal C polysaccharide vaccination","volume":"178","author":"Granoff","year":"1998","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD001834.pub3-BIB60|cit60","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1086\/340050","article-title":"Influence of serogroup on the presentation, course, and outcome of invasive meningococcal disease in children in the Republic of Ireland, 1995-2000","volume":"34","author":"Healy","year":"2002","journal-title":"Clinical Infectious Diseases"},{"issue":"2","key":"10.1002\/14651858.CD001834.pub3-BIB61|cit61","first-page":"21","article-title":"Laboratory-based surveillance for meningococcal disease in selected areas, United States, 1989-1991","volume":"42","author":"Jackson","year":"1993","journal-title":"Morbidity and Mortality Weekly Report"},{"issue":"1","key":"10.1002\/14651858.CD001834.pub3-BIB62|cit62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomised clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"issue":"3","key":"10.1002\/14651858.CD001834.pub3-BIB63|cit63","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1006\/biol.2000.0253","article-title":"Standardisation and validation of serological assays for the evaluation of immune responses to Neisseria meningitidis serogroup A and C vaccines","volume":"28","author":"Jodar","year":"2000","journal-title":"Biologicals"},{"key":"10.1002\/14651858.CD001834.pub3-BIB64|cit64","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/S0140-6736(02)08416-7","article-title":"Development of vaccines against meningococcal disease","volume":"359","author":"Jodar","year":"2002","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001834.pub3-BIB65|cit65","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.vaccine.2003.08.040","article-title":"Scientific challenges for the quality control and production of group C meningococcal conjugate vaccine","volume":"22","author":"Jodar","year":"2004","journal-title":"Vaccine"},{"issue":"1","key":"10.1002\/14651858.CD001834.pub3-BIB66|cit66","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0163-4453(93)93978-D","article-title":"Age incidence of meningococcal infection, England and Wales, 1984-1991","volume":"27","author":"Jones","year":"1993","journal-title":"Journal of Infection"},{"issue":"3","key":"10.1002\/14651858.CD001834.pub3-BIB67|cit67","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2165\/00003495-199855030-00003","article-title":"Meningococcal vaccines. Current status and future possibilities","volume":"55","author":"Peltola","year":"1998","journal-title":"Drugs"},{"key":"10.1002\/14651858.CD001834.pub3-BIB68|cit68","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1086\/376997","article-title":"Estimating Haemophylus influenzae Type b Vaccine effectiveness in England and Wales by use of the screening methods","volume":"188","author":"Ramsay","year":"2003","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD001834.pub3-BIB69|cit69","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/bmj.326.7385.365","article-title":"Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis","volume":"326","author":"Ramsay","year":"2003","journal-title":"BMJ"},{"issue":"14","key":"10.1002\/14651858.CD001834.pub3-BIB70|cit70","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1001\/jama.276.14.1181","article-title":"The 1996 Albert Lasker Medical Research Awards. Prevention of systemic infections, especially meningitis, caused by Haemophilus influenzae type b. Impact on public health and implications for other polysaccharide-based vaccines","volume":"276","author":"Robbins","year":"1996","journal-title":"JAMA"},{"issue":"3","key":"10.1002\/14651858.CD001834.pub3-BIB71|cit71","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1128\/CDLI.8.3.616-623.2001","article-title":"Importance of complement source in measuring meningococcal bactericidal titers","volume":"8","author":"Santos","year":"2001","journal-title":"Clinical and Diagnostic Laboratory Immunology"},{"issue":"6","key":"10.1002\/14651858.CD001834.pub3-BIB72|cit72","first-page":"861","article-title":"Association of meningococcal serogroups with the course of disease in the Netherlands, 1959-83","volume":"65","author":"Spanjaard","year":"1987","journal-title":"Bulletin of the World Health Organization"},{"issue":"3-4","key":"10.1002\/14651858.CD001834.pub3-BIB73|cit73","first-page":"170","article-title":"Meningococcal disease: public health burden and control","volume":"50","author":"Tikhomirov","year":"1997","journal-title":"World Health Statistics Quarterly"},{"issue":"40","key":"10.1002\/14651858.CD001834.pub3-BIB74|cit74","first-page":"329","article-title":"Meningococcal disease: treatment and prevention","volume":"77","author":"Wall","year":"2002","journal-title":"Annals of Internal Medicine"},{"issue":"40","key":"10.1002\/14651858.CD001834.pub3-BIB75|cit75","first-page":"329","article-title":"Meningococcal vaccines: polysaccharide and polysaccharide conjugate vaccines","volume":"77","author":"WHO","year":"2002","journal-title":"Weekly Epidemiological Record"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD001834.pub3\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T10:50:22Z","timestamp":1704192622000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD001834.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Acute Respiratory Infections Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2011,7,6]]},"references-count":75,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2011,7]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd001834.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,6]]}}}